These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 19445003)

  • 1. Sputum eosinophil count in athletes with antiasthmatic therapeutic use exemption.
    Lippi G; Banfi G; Guidi GC
    Med Sci Sports Exerc; 2008 Sep; 40(9):1707; author reply 1708. PubMed ID: 19445003
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of sputum eosinophil counts to guide management in children with severe asthma.
    Fleming L; Bush A
    Thorax; 2012 Nov; 67(11):1015-6; author reply 1016. PubMed ID: 22802332
    [No Abstract]   [Full Text] [Related]  

  • 3. Asthma in elite athletes: how do we manage asthma-like symptoms and asthma in elite athletes?
    Lund TK
    Clin Respir J; 2009 Apr; 3(2):123. PubMed ID: 20298392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of mepolizumab on the sputum level of eosinophil-derived protein in three cases of severe asthma.
    Koya T; Kimura Y; Hayashi M; Hasegawa T; Kikuchi T
    Allergol Int; 2020 Oct; 69(4):639-641. PubMed ID: 32439281
    [No Abstract]   [Full Text] [Related]  

  • 5. [Eosinophil count in induced sputum samples as a marker of airway inflammation and adequacy of corticosteroid inhalation treatment in asthmatic patients].
    Tomii K; Matsumura Y; Taguchi Y; Oida K; Kobash Y
    Nihon Kokyuki Gakkai Zasshi; 1998 Feb; 36(2):138-43. PubMed ID: 9617140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma.
    Katz LE; Gleich GJ; Hartley BF; Yancey SW; Ortega HG
    Ann Am Thorac Soc; 2014 May; 11(4):531-6. PubMed ID: 24606022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review and meta-analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils).
    Petsky HL; Cates CJ; Lasserson TJ; Li AM; Turner C; Kynaston JA; Chang AB
    Thorax; 2012 Mar; 67(3):199-208. PubMed ID: 20937641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High blood eosinophil counts predict sputum eosinophilia in patients with severe asthma.
    Fowler SJ; Tavernier G; Niven R
    J Allergy Clin Immunol; 2015 Mar; 135(3):822-4.e2. PubMed ID: 25445828
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of local eosinophilopoietic processes in the development of airway eosinophilia in prednisone-dependent severe asthma.
    Sehmi R; Smith SG; Kjarsgaard M; Radford K; Boulet LP; Lemiere C; Prazma CM; Ortega H; Martin JG; Nair P
    Clin Exp Allergy; 2016 Jun; 46(6):793-802. PubMed ID: 26685004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits of induced sputum for the evaluation of therapeutic efficacy in patients with bronchial asthma.
    Ohnishi H; Maeda H; Nishimura Y; Yokoyama M
    Kobe J Med Sci; 1998 Aug; 44(4):149-61. PubMed ID: 10352494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammometry: the current state of play.
    Pavord ID; Gibson PG
    Thorax; 2012 Mar; 67(3):191-2. PubMed ID: 22344396
    [No Abstract]   [Full Text] [Related]  

  • 12. Asthma and exercise-induced bronchoconstriction in athletes.
    Boulet LP; O'Byrne PM
    N Engl J Med; 2015 Feb; 372(7):641-8. PubMed ID: 25671256
    [No Abstract]   [Full Text] [Related]  

  • 13. A randomized controlled trial on the effect of montelukast on sputum eosinophil cationic protein in children with corticosteroid-dependent asthma.
    Strauch E; Moske O; Thoma S; Storm Van's Gravesande K; Ihorst G; Brandis M; Kuehr J
    Pediatr Res; 2003 Aug; 54(2):198-203. PubMed ID: 12736396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of changes in anti-doping regulations (WADA Guidelines) on asthma care in athletes.
    Couto M; Horta L; Delgado L; Capão-Filipe M; Moreira A
    Clin J Sport Med; 2013 Jan; 23(1):74-6. PubMed ID: 22948449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asthma and athletes: therapy to compete.
    Weiler JM; Malloy C
    Clin Rev Allergy Immunol; 2005 Oct; 29(2):139-49. PubMed ID: 16251768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemically stained activated eosinophils in sputum in patients with asthma.
    Jang AS; Choi IS; Park CS
    Respiration; 2000; 67(2):183-8. PubMed ID: 10773791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sputum interleukin-13 as a biomarker for the evaluation of asthma control.
    Tsilogianni Z; Hillas G; Bakakos P; Aggelakis L; Konstantellou E; Papaioannou AI; Papaporfyriou A; Papiris S; Koulouris N; Loukides S; Kostikas K
    Clin Exp Allergy; 2016 Jul; 46(7):923-31. PubMed ID: 26990030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sputum and blood eosinophils during corticosteroid treatment of acute exacerbations of asthma.
    Baigelman W; Chodosh S; Pizzuto D; Cupples LA
    Am J Med; 1983 Dec; 75(6):929-36. PubMed ID: 6650547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are sputum eosinophil cationic protein and eosinophils differently associated with clinical and functional findings of asthma?
    Cianchetti S; Bacci E; Ruocco L; Pavia T; Bartoli ML; Cardini C; Costa F; Di Franco A; Malagrinò L; Novelli F; Vagaggini B; Celi A; Dente F; Paggiaro P
    Clin Exp Allergy; 2014; 44(5):673-80. PubMed ID: 24245689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of different anti-asthmatic agents on induced sputum and eosinophil cationic protein in mild asthmatics.
    Basyigit I; Yildiz F; Kacar Ozkara S; Boyaci H; Ilgazli A; Ozkarakas O
    Respirology; 2004 Nov; 9(4):514-20. PubMed ID: 15612964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.